Zymeworks Inc
NASDAQ:ZYME

Watchlist Manager
Zymeworks Inc Logo
Zymeworks Inc
NASDAQ:ZYME
Watchlist
Price: 23.17 USD 0.3% Market Closed
Market Cap: 1.7B USD

Wall Street
Price Targets

ZYME Price Targets Summary
Zymeworks Inc

Wall Street analysts forecast ZYME stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ZYME is 36.25 USD with a low forecast of 30.3 USD and a high forecast of 44.1 USD.

Lowest
Price Target
30.3 USD
31% Upside
Average
Price Target
36.25 USD
56% Upside
Highest
Price Target
44.1 USD
90% Upside
Zymeworks Inc Competitors:
Price Targets
KURA
Kura Oncology Inc
258% Upside
002252
Shanghai RAAS Blood Products Co Ltd
10% Upside
ABNX
Abionyx Pharma SA
197% Upside
EXAS
Exact Sciences Corp
1% Downside
VITR
Vitrolife AB
47% Upside
688428
InnoCare Pharma Ltd
75% Upside
688278
Xiamen Amoytop Biotech Co Ltd
25% Upside
068270
Celltrion Inc
3% Upside

Revenue
Forecast

Revenue Estimate
Zymeworks Inc

For the last 9 years the compound annual growth rate for Zymeworks Inc's revenue is 26%. The projected CAGR for the next 4 years is 33%.

26%
Past Growth
33%
Estimated Growth
Estimates Accuracy
5%
Average Beat

Operating Income
Forecast

Operating Income Estimate
Zymeworks Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-10%
Average Miss

Net Income
Forecast

Net Income Estimate
Zymeworks Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-37%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ZYME's stock price target?
Price Target
36.25 USD

According to Wall Street analysts, the average 1-year price target for ZYME is 36.25 USD with a low forecast of 30.3 USD and a high forecast of 44.1 USD.

What is Zymeworks Inc's Revenue forecast?
Projected CAGR
33%

For the last 9 years the compound annual growth rate for Zymeworks Inc's revenue is 26%. The projected CAGR for the next 4 years is 33%.

Back to Top